Zhengrong Li

Title: Zhengrong Li: Innovator in Complement-Associated Conditions

Introduction

Zhengrong Li is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of degenerative diseases. With a total of 2 patents, his work focuses on innovative methods and compositions that address critical health issues.

Latest Patents

Li's latest patents include "Compositions and method for treating complement-associated conditions." This invention provides methods and compositions for treating various degenerative diseases, such as age-related macular degeneration (AMD), using a factor D inhibitor, which may include an anti-factor D antibody or an antigen-binding fragment thereof. Additionally, the patent outlines methods for selecting or identifying patients for treatment with a factor D inhibitor, utilizing prognostic and predictive biomarkers. Another significant patent is "Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms," which also focuses on treating degenerative diseases with similar methodologies.

Career Highlights

Zhengrong Li is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to explore and develop groundbreaking treatments that have the potential to improve patient outcomes significantly.

Collaborations

Li has collaborated with notable colleagues, including Brian Yaspan and Robert Royal Graham. These partnerships have fostered an environment of innovation and have contributed to the advancement of research in the field.

Conclusion

Zhengrong Li's contributions to the field of medicine through his patents and work at Genentech highlight his commitment to addressing complex health challenges. His innovative approaches continue to pave the way for advancements in the treatment of degenerative diseases.